| Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial CS Calfee, KL Delucchi, P Sinha, MA Matthay, J Hackett, M Shankar-Hari, ... The Lancet Respiratory Medicine 6 (9), 691-698, 2018 | 537 | 2018 |
| Rapamycin regulates autophagy and cell adhesion in induced pluripotent stem cells A Sotthibundhu, K McDonagh, A von Kriegsheim, A Garcia-Munoz, ... Stem Cell Research & Therapy 7, 1-16, 2016 | 79 | 2016 |
| NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families M Al Shehhi, EB Forman, JE Fitzgerald, V McInerney, J Krawczyk, S Shen, ... European journal of medical genetics 62 (3), 204-209, 2019 | 60 | 2019 |
| Increased Ca2+ signaling in NRXN1α+/− neurons derived from ASD induced pluripotent stem cells S Avazzadeh, K McDonagh, J Reilly, Y Wang, SD Boomkamp, ... Molecular Autism 10, 1-16, 2019 | 34 | 2019 |
| Autologous bone marrow mesenchymal stromal cell therapy for “no-option” critical limb ischemia is limited by karyotype abnormalities SA Mohamed, L Howard, V McInerney, A Hayat, J Krawczyk, S Naughton, ... Cytotherapy 22 (6), 313-321, 2020 | 33 | 2020 |
| The development of translational biomarkers as a tool for improving the understanding, diagnosis and treatment of chronic neuropathic pain DA Buckley, EM Jennings, NN Burke, M Roche, V McInerney, JD Wren, ... Molecular Neurobiology 55, 2420-2430, 2018 | 20 | 2018 |
| NRXN1α+/- is associated with increased excitability in ASD iPSC-derived neurons S Avazzadeh, LR Quinlan, J Reilly, K McDonagh, A Jalali, Y Wang, ... BMC neuroscience 22, 1-14, 2021 | 16 | 2021 |
| First safety and performance evaluation of T45K, a self-assembling peptide barrier hemostatic device, after skin lesion excision G Rahmani, J Prats, T Norchi, S Kates, V McInerney, J Woods, J Kelly Dermatologic Surgery 44 (7), 939-948, 2018 | 12 | 2018 |
| Safety and preliminary efficacy of mesenchymal stromal cell (ORBCEL-M) therapy in diabetic kidney disease: a randomized clinical trial (NEPHSTROM) N Perico, G Remuzzi, MD Griffin, P Cockwell, AP Maxwell, F Casiraghi, ... Journal of the American Society of Nephrology 34 (10), 1733-1751, 2023 | 8 | 2023 |
| Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c. 1201dupC … N Ge, M Liu, Y Ding, J Krawczyk, V McInerney, J Galvin, S Shen, ... Stem Cell Research 41, 101650, 2019 | 7 | 2019 |
| Using quality of life information in the clinical setting: a randomised controlled trial of using subjective quality of life and symptom outcome measures as a clinical tool in … V Mcinerney Doctoral dissertation, 2015 | 7 | 2015 |
| Generation of three induced pluripotent stem cell (iPSC) lines from a patient with developmental epileptic encephalopathy due to the pathogenic KCNA2 variant c. 869T> G; p … A Arbini, J Gilmore, MD King, KM Gorman, J Krawczyk, V McInerney, ... Stem Cell Research 46, 101853, 2020 | 4 | 2020 |
| Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c. 1697C> A mutation (NUIGi005-A … N Ge, M Liu, J Krawczyk, V McInerney, J Galvin, S Shen, T O'Brien, ... Stem Cell Research 39, 101502, 2019 | 4 | 2019 |
| Using individual quality-of-life information as a clinical tool in patients with advanced cancer. VB McInerney, D Waldron, E Mannion Journal of Clinical Oncology 33 (29_suppl), 91-91, 2015 | 4 | 2015 |
| Generation and characterization of two induced pluripotent stem cell lines (NUIGi038-A, NUIGi038-B) from dermal fibroblasts of a healthy individual N Ge, M Liu, X Zhu, J Krawczyk, V McInerney, S Shen, T O'Brien, ... Stem Cell Research 49, 101996, 2020 | 3 | 2020 |
| Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A) Y Ding, E Carvalho, C Murphy, V McInerney, J Krawczyk, T O'Brien, ... Stem Cell Research 43, 101665, 2020 | 3 | 2020 |
| GMP-compliant production of autologous adipose-derived stromal cells in the NANT 001 closed automated bioreactor JC Fitzgerald, N Duffy, G Cattaruzzi, F Vitrani, A Paulitti, F Mazzarol, ... Frontiers in Bioengineering and Biotechnology 10, 834267, 2022 | 2 | 2022 |
| Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c. 2464G> A … N Ge, M Liu, J Krawczyk, V McInerney, D Ward, S Shen, T O'Brien, ... Stem Cell Research 49, 101997, 2020 | 2 | 2020 |
| Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c. 638C> T; p … R Stewart, C Gadoud, J Krawczyk, V McInerney, T O'Brien, S Shen, ... Stem Cell Research 69, 103093, 2023 | 1 | 2023 |
| Vascular access device type for systemic anti-cancer therapies: a scoping review protocol C Duggan, O Hernon, R Dunne, V McInerney, SR Walsh, PJ Carr British Journal of Nursing 32 (7), S18-S22, 2023 | 1 | 2023 |
